1. Home
  2. RGEN vs CUBE Comparison

RGEN vs CUBE Comparison

Compare RGEN & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CUBE
  • Stock Information
  • Founded
  • RGEN 1981
  • CUBE 2004
  • Country
  • RGEN United States
  • CUBE United States
  • Employees
  • RGEN N/A
  • CUBE N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CUBE Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • CUBE Real Estate
  • Exchange
  • RGEN Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • RGEN 7.1B
  • CUBE 8.1B
  • IPO Year
  • RGEN N/A
  • CUBE 2004
  • Fundamental
  • Price
  • RGEN $145.23
  • CUBE $39.96
  • Analyst Decision
  • RGEN Buy
  • CUBE Buy
  • Analyst Count
  • RGEN 12
  • CUBE 13
  • Target Price
  • RGEN $175.56
  • CUBE $48.54
  • AVG Volume (30 Days)
  • RGEN 953.7K
  • CUBE 1.9M
  • Earning Date
  • RGEN 04-29-2025
  • CUBE 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • CUBE 5.21%
  • EPS Growth
  • RGEN N/A
  • CUBE N/A
  • EPS
  • RGEN N/A
  • CUBE 1.72
  • Revenue
  • RGEN $634,439,000.00
  • CUBE $1,068,730,000.00
  • Revenue This Year
  • RGEN $12.29
  • CUBE $1.15
  • Revenue Next Year
  • RGEN $15.20
  • CUBE $3.24
  • P/E Ratio
  • RGEN N/A
  • CUBE $23.23
  • Revenue Growth
  • RGEN 0.33
  • CUBE 1.31
  • 52 Week Low
  • RGEN $102.97
  • CUBE $34.24
  • 52 Week High
  • RGEN $182.52
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 59.03
  • CUBE 50.73
  • Support Level
  • RGEN $125.05
  • CUBE $38.01
  • Resistance Level
  • RGEN $148.94
  • CUBE $40.40
  • Average True Range (ATR)
  • RGEN 10.09
  • CUBE 1.62
  • MACD
  • RGEN 3.52
  • CUBE 0.23
  • Stochastic Oscillator
  • RGEN 91.93
  • CUBE 84.54

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: